EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Resolvin D1 suppresses inflammation in human fibroblast-like synoviocytes via the p-38, NF-κB, and AKT signaling pathways

Makoto Yanoshita, Naoto Hirose, Sayuri Nishiyama, Eri Tsuboi, Naoki Kubo, Daiki Kita, Kotaro Tanimoto

In Vitro Cellular & Developmental Biology - Animal · 2025

DOI: 10.1007/s11626-024-01008-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift In Vitro Cellular & Developmental Biology - Animal, 2025. Verfasst von Makoto Yanoshita und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthodontics and Craniofacial Developmental Biology, Hiroshima University Graduate School of Biomedical and Health Sciences, Kasumi 1-2…. Hauptthemen laut MEDLINE: Synoviocytes, Docosahexaenoic Acids, Proto-Oncogene Proteins c-akt, NF-kappa B. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science KAKENHI Grant, Hiroshima University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Synovitis represents the initial pathological change in osteoarthritis and contributes to its progression. Resolvin D1 (RV-D1) is a novel and endogenous docosahexaenoic acid-derived lipid mediator, which regulates the duration and magnitude of inflammation by downregulating pro-inflammatory genes and mediators. However, the effects of RV-D1 on synovitis remain unknown. The aim of the present study was to investigate the anti-inflammatory effects of RV-D1 in human fibroblast-like synoviocytes (HFLSs) and the underlying mechanisms. The expression of the HFLS formyl peptide receptor 2 (ALX/FPR) was examined via immunocytochemical analysis. HFLSs were treated with 1 ng/mL recombinant human interleukin-1β (IL-1β) and RV-D1. The gene expression of interleukin-1β ( IL1B ), matrix metalloproteinase 3 ( MMP3 ), and MMP13 was examined using real-time reverse transcription-polymerase chain reaction after treatment with IL-1β and RV-D1. The effect of RV-D1 on apoptosis was examined based on fluorescence intensity. Phosphorylation of p-38, extracellular signal-regulated kinase, c-Jun N-terminal kinase, nuclear factor kappa B (NF-κB), and AKT was analyzed via western blotting. ALX/FPR staining was observed on the cell surface. RV-D1 significantly suppressed the IL-1β-induced increase in gene and protein expression of IL-1β, MMP-3, and MMP-13. Pretreatment with 100 nM RV-D1 significantly increased the fluorescence intensity compared to that in the non-treatment group. Furthermore, pretreatment with RV-D1 significantly suppressed the phosphorylation of p-38, NF-κB, and AKT. Whereas WRW4, an antagonist of ALX/ FPR2, treatment weakened the effect of RV-D1, resulting in p-38, NF-κB, and AKT phosphorylation and the protein expression of MMP-13 at levels comparable to those in the IL-1β without RV-D1. In conclusion, RV-D1 suppressed IL-1β and MMP expression by inhibiting the phosphorylation of p-38, NF-κB, and AKT in inflammation in HFLSs. RV-D1 can be used to develop treatments for osteoarthritis and other inflammatory disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SynoviocytesDocosahexaenoic AcidsProto-Oncogene Proteins c-aktNF-kappa BFibroblastsSignal TransductionInflammationHumansInterleukin-1betaMatrix Metalloproteinase 13PhosphorylationApoptosisMatrix Metalloproteinase 3Receptors, Formyl PeptideGene Expression RegulationReceptors, Lipoxin

Stichwörter der Autor:innen

Endogenous docosahexaenoic acid-derived lipid mediatorFibroblast-like synoviocytesInflammatory disordersOsteoarthritisResolvin D1

Substanzen

Docosahexaenoic AcidsProto-Oncogene Proteins c-aktNF-kappa Bresolvin D1Interleukin-1betaMatrix Metalloproteinase 13Matrix Metalloproteinase 3Receptors, Formyl PeptideReceptors, Lipoxin

Autor:innen und Institutionen

  • Department of Orthodontics and Craniofacial Developmental Biology, Hiroshima University Graduate School of Biomedical and Health Sciences, Kasumi 1-2-3 Minami-Ku, Hiroshima-Shi, Hiroshima Prefecture, Japan.
  • Department of Orthodontics and Craniofacial Developmental Biology, Hiroshima University Graduate School of Biomedical and Health Sciences, Kasumi 1-2-3 Minami-Ku, Hiroshima-Shi, Hiroshima Prefecture, Japan. hirose@hiros…

Förderung

  • Japan Society for the Promotion of Science KAKENHI Grant
  • Hiroshima University

Zitieren

APA

Yanoshita, M., Hirose, N., Nishiyama, S., Tsuboi, E., Kubo, N., Kita, D., & Tanimoto, K. (2025). Resolvin D1 suppresses inflammation in human fibroblast-like synoviocytes via the p-38, NF-κB, and AKT signaling pathways. In Vitro Cellular & Developmental Biology - Animal. https://doi.org/10.1007/s11626-024-01008-9

Vancouver

Yanoshita M, Hirose N, Nishiyama S, Tsuboi E, Kubo N, Kita D, et al. Resolvin D1 suppresses inflammation in human fibroblast-like synoviocytes via the p-38, NF-κB, and AKT signaling pathways. In Vitro Cellular & Developmental Biology - Animal. 2025. doi:10.1007/s11626-024-01008-9

BibTeX
@article{Yanoshita2025,
  author = {Yanoshita, Makoto and Hirose, Naoto and Nishiyama, Sayuri and Tsuboi, Eri and Kubo, Naoki and Kita, Daiki and Tanimoto, Kotaro},
  title = {Resolvin D1 suppresses inflammation in human fibroblast-like synoviocytes via the p-38, NF-κB, and AKT signaling pathways},
  journal = {In Vitro Cellular & Developmental Biology - Animal},
  year = {2025},
  doi = {10.1007/s11626-024-01008-9}
}
Kostenlos starten →